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Background:  Bone marrow (BM) metabolic activity is increased after ACS and is associated with release of pro-inflammatory leukocytes and 
arterial inflammation. However, the relationship of BM activity to cardiovascular disease (CVD) events remains unknown.
Methods:  We identified 513 individuals free of cancer or prior CVD (age 56±13, 42% male) who underwent 18F-FDG-PET/CT imaging. Metabolic 
activity in vertebral BM and arterial inflammation were assessed as Standardized Uptake Value (SUV) and as background (blood) corrected SUVC. 
Coronary artery calcium (CAC) was measured using CT. While blinded to imaging data, clinical records were reviewed to adjudicate incidence of pre-
defined CVD events during follow-up.
results:  During follow-up (median, 4.2 years), 44 subjects experienced CVD events. At baseline, BM activity significantly correlated with arterial 
inflammation, as SUV (Fig 1) and SUVC (R=0.58, p<0.001). In a Cox-regression model, baseline BM SUV was independently associated with incident 
CVD after adjusting for Framingham Risk Score (FRS) and CAC (B=0.51, p<0.001) or for arterial SUVC (B=0.41, p<0.001). Individuals with BM SUV > 
median value had increased risk of CVD events (hazard ratio=2.3, Fig 2).
conclusions:  BM metabolism, an index of progenitor cell activity, is strongly associated with future cardiovascular events independently of FRS, 
CAC and measures of arterial inflammation. BM metabolic activity may serve as a novel imaging biomarker that warrants further investigation.
